相关实验视频
Updated: Jul 17, 2025

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.9K
对胆固醇的抵抗 胆结石疾病:肝胆固醇代谢 胆固醇代谢
Chenghao Zhang1, Wanlin Dai2, Shaojie Yang1
1Biliary Surgery (2nd General) Unit, Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
The Journal of clinical endocrinology and metabolism
|September 5, 2023
概括
胆固醇胆结石疾病 (CGD) 源于肝脏胆固醇代谢异常. 本综述探讨了关键的分子变化和治疗策略,将肝胆固醇与CGD和非酒精性脂肪性肝病 (NAFLD) 联系起来.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 胃肠病学 胃肠病学
背景情况:
- 胆固醇胆结石疾病 (CGD) 是一种与肝脏胆固醇代谢相关的流行消化系统疾病.
- 异常包括过度的肝脏胆固醇合成,受损的吸收/出口,以及改变的化.
- CGD与非酒精性脂肪性肝病 (NAFLD) 有共同的联系.
研究的目的:
- 审查胆结石病 (GSD) 的临床诊断和治疗.
- 要总结肝脏胆固醇代谢过程和CGD患者的分子变化.
- 分析最近在CGD病原体,治疗点和CGD-NAFLD关系方面的进展.
主要方法:
- 关于肝脏胆固醇代谢和CGD的临床和分子研究的文献综述.
- 对胆结石患者关键分子表达变化的分析.
- 综合关于CGD病原和治疗策略的当前研究.
主要成果:
- 确定了与CGD相关的肝脏胆固醇代谢中的关键分子变化.
- 突出了影响CGD的显著分子标.
- 讨论了CGD和NAFLD之间的复杂关系.
结论:
- 肝脏胆固醇代谢在CGD发展中起着至关重要的作用.
- 了解这些代谢途径为CGD和NAFLD提供了潜在的治疗点.
- 新兴的策略集中在调节肝脏胆固醇以预防和治疗胆结石疾病.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
697
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
697
Cholesterol: Significance and Regulation
581
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
581
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
144
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
144
Hepatic Drug Clearance: Role of Transporters
83
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
83
Lipids: Dietary Sources and Requirements
827
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
827
Hepatic Drug Clearance: Effect of Protein Binding
241
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
241

